| Hannah Mehrhoff, OTR/L | |
|
14130 23rd Ave N, Plymouth, MN 55447 | |
| (763) 383-7666 | |
| (763) 383-6013 |
| Full Name | Hannah Mehrhoff |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 14130 23rd Ave N, Plymouth, Minnesota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891403705 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225XM0800X | Occupational Therapist - Mental Health | 106850 (Minnesota) | Secondary |
| 225X00000X | Occupational Therapist | 106850 (Minnesota) | Primary |
| Provider Name | Nystrom & Associates Ltd |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1396750188 PECOS PAC ID: 6406752492 Enrollment ID: O20031210000592 |
News Archive
Merck/Schering-Plough Pharmaceuticals today announced the regulatory approval of INEGYTM (ezetimibe/simvastatin) in Germany for the treatment of elevated cholesterol (hypercholesterolemia). INEGY is the first product to reduce low-density lipoprotein cholesterol (LDL-C or ‘bad' cholesterol), along with diet and exercise, through dual inhibition by inhibiting cholesterol production in the liver and absorption in the intestine. The approval of INEGY in Germany represents the first approval in Europe for ezetimibe/simvastatin tablets and the first step in seeking marketing approval throughout the European Union (EU) under the EU's mutual recognition procedure.
Ventrus Biosciences Inc., a pharmaceutical company focused on developing and commercializing gastrointestinal products, today announced the pricing of its initial public offering of 2,900,000 shares at $6.00 per share. The shares are expected to begin trading tomorrow, December 17, 2010 on the Nasdaq Capital Market under the symbol "VTUS". In addition, Ventrus has granted the underwriters a 45-day option to purchase up to an additional 435,000 shares to cover over-allotments, if any.
Because eye injuries are rarely serious enough to require hospitalization, to understand the extent of eye injuries in the U.S., inpatient and outpatient facilities, in addition to other settings, must be considered, according to background information in the article.
At the European Congress of Radiology 2011, Royal Philips Electronics is ushering in a new era in radiology science with Imaging 2.0, a concept fueled by integration of technology, clinician and patient.
CPhI's annual conference, Polymorphism 2012, is a two-day strategic meet taking place from 19-20 December at Hilton International Airport, Mumbai, India. This event has received a lot of interest from the pharma industry as it focuses on a very technical and important subject of polymorphism studies that poses challenges to this industry and excellence in this area is vital for this sector's continued growth.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Hannah Mehrhoff, OTR/L 14130 23rd Ave, Plymouth, MN 55447 Ph: (763) 383-7666 | Hannah Mehrhoff, OTR/L 14130 23rd Ave N, Plymouth, MN 55447 Ph: (763) 383-7666 |
News Archive
Merck/Schering-Plough Pharmaceuticals today announced the regulatory approval of INEGYTM (ezetimibe/simvastatin) in Germany for the treatment of elevated cholesterol (hypercholesterolemia). INEGY is the first product to reduce low-density lipoprotein cholesterol (LDL-C or ‘bad' cholesterol), along with diet and exercise, through dual inhibition by inhibiting cholesterol production in the liver and absorption in the intestine. The approval of INEGY in Germany represents the first approval in Europe for ezetimibe/simvastatin tablets and the first step in seeking marketing approval throughout the European Union (EU) under the EU's mutual recognition procedure.
Ventrus Biosciences Inc., a pharmaceutical company focused on developing and commercializing gastrointestinal products, today announced the pricing of its initial public offering of 2,900,000 shares at $6.00 per share. The shares are expected to begin trading tomorrow, December 17, 2010 on the Nasdaq Capital Market under the symbol "VTUS". In addition, Ventrus has granted the underwriters a 45-day option to purchase up to an additional 435,000 shares to cover over-allotments, if any.
Because eye injuries are rarely serious enough to require hospitalization, to understand the extent of eye injuries in the U.S., inpatient and outpatient facilities, in addition to other settings, must be considered, according to background information in the article.
At the European Congress of Radiology 2011, Royal Philips Electronics is ushering in a new era in radiology science with Imaging 2.0, a concept fueled by integration of technology, clinician and patient.
CPhI's annual conference, Polymorphism 2012, is a two-day strategic meet taking place from 19-20 December at Hilton International Airport, Mumbai, India. This event has received a lot of interest from the pharma industry as it focuses on a very technical and important subject of polymorphism studies that poses challenges to this industry and excellence in this area is vital for this sector's continued growth.
› Verified 8 days ago
Maggie Caroline Rees, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 3021 Harbor Ln N Ste 120, Plymouth, MN 55447 Phone: 651-773-0354 | |
Kelly Greeninger, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 15700 37th Ave N Ste 220, Plymouth, MN 55446 Phone: 651-968-5600 | |
Laura Solverson, MA, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 14130 23rd Ave N, Plymouth, MN 55447 Phone: 763-383-7666 Fax: 763-383-6013 | |
Bryn Elizabeth Wasserman, MA OTRL Occupational Therapist Medicare: Medicare Enrolled Practice Location: 3001 Harbor Lane North, Suite 120, Plymouth, MN 55447 Phone: 651-773-0354 Fax: 651-773-0371 | |
Sandra Hage, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4665 Deerwood Ln N, Plymouth, MN 55442 Phone: 612-508-3985 | |
Kelly Ann Holden, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 10713 32nd Ave N, Plymouth, MN 55441 Phone: 612-709-3102 | |
Summer L Shepstone, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 14130 23rd Ave N, Plymouth, MN 55447 Phone: 312-238-1000 |